Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review
Alexandros L. Liarakos, Anastasios Tentolouris, Alexandros Kokkinos, Ioanna Eleftheriadou, Nikolaοs Tentolouris
Topics & Concepts
MedicineDiabetes mellitusType 2 diabetesType 2 Diabetes MellitusMacrovascular diseaseObservational studyDapagliflozinInternal medicineGlucagon-like peptide 1 receptorIntensive care medicineEndocrinologyReceptorAgonistDiabetes Treatment and ManagementPharmacology and Obesity TreatmentPeripheral Artery Disease Management